Compare SWKS & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SWKS | TWST |
|---|---|---|
| Founded | 1962 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.2B |
| IPO Year | 1995 | 2018 |
| Metric | SWKS | TWST |
|---|---|---|
| Price | $88.68 | $166.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 8 |
| Target Price | ★ $70.38 | $46.88 |
| AVG Volume (30 Days) | ★ 6.6M | 1.6M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.53% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $4,086,900,000.00 | $376,572,000.00 |
| Revenue This Year | N/A | $18.91 |
| Revenue Next Year | $3.06 | $15.07 |
| P/E Ratio | $92.24 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $51.93 | $23.30 |
| 52 Week High | $92.30 | $163.70 |
| Indicator | SWKS | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 70.79 |
| Support Level | $54.32 | $39.81 |
| Resistance Level | $92.30 | N/A |
| Average True Range (ATR) | 5.53 | 8.92 |
| MACD | 1.57 | 1.47 |
| Stochastic Oscillator | 85.83 | 94.55 |
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.